Author Question: A recent report in which a major pharmaceutical company released the results of testing that had ... (Read 77 times)

HCHenry

  • Hero Member
  • *****
  • Posts: 591
A recent report in which a major pharmaceutical company released the results of testing that had been done on the cholesterol reduction that people could expect if they use the company's new drug indicated that the Type II error probability for a
 
  given true mean was 0.1250 based on the sample size of n = 64 subjects. Given this, what was the power of the test under these same conditions? The alpha level used in the test was 0.05.A) 0.95
  B) 0.875
  C) Essentially zero
  D) Power would be undefined in this case since the hypothesis would be rejected.

Question 2

The number of weeds that remain living after a specific chemical has been applied averages 1.3 per square yard and follows a Poisson distribution. Based on this, what is the probability that a 1-square yard section will contain less than 4 weeds?
 
  A) 0.0324
  B) 0.0998
  C) Nearly 0.5000
  D) 0.9569



guyanai

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library